Plasma GDF15 concentration predicts early recurrence after atrial arrhythmia ablation.
Where this comes from
- Record sourced from PubMed, PMID 41734019.
- Also identified by DOI 10.1172/jci.insight.198444.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<div> <div> <div> <div> <div> <div> A blood marker called GDF15, measured before ablation, can predict arrhythmia recurrence within 24 hours, suggesting immune reactions influence healing and treatment success. </div> </div> </div> </div> </div> </div>.
Medical subject headings
- Growth Differentiation Factor 15
- Atrial Fibrillation
- Catheter Ablation